CICigna Group company profile
$297.00+0.25%Close 13 Nov 2026 · Market value $78.76B
About Cigna Group
The Cigna Group is a global health company operating through two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services provides pharmacy benefit services, including retail pharmacy network administration, home delivery and specialty pharmacies, and care services, to clients such as managed care organizations, health insurers, employers, and government health programs. Cigna Healthcare provides medical plans and related solutions through U.S. Healthcare, which serves insured and self-insured clients and individual and family plan customers, and through International Health, which serves multinational employers, globally mobile individuals, and residents of selected countries outside the United States. The company reports approximately 67,700 colleagues and more than 185 million customer relationships in more than 30 markets and jurisdictions as of December 31, 2025.
A summary of the business section of the company's latest annual report, filed 26 Feb 2026.
Company facts
| Ticker | CI · NYSE |
|---|
| Sector | Insurance |
|---|
| Industry | Health Care Services |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 1739940 |
|---|
| Latest annual report | 10-K, filed 26 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| David M. Cordani | Chairman & CEO · Director | 1.2M · < 1% | Option exercise, 13 May 2026 |
|---|
| Brian C. Evanko | See Remarks | 167K · < 1% | Grant or award, 1 Sep 2026 |
|---|
| Nicole S. Jones | See Remarks | 104K · < 1% | Sale under a 10b5-1 plan, 18 Aug 2026 |
|---|
| Eric P. Palmer | See Remarks | 71.4K · < 1% | Grant or award, 28 Feb 2025 |
|---|
| Eric J. Foss | Director | 35.3K · < 1% | Grant or award, 22 Apr 2026 |
|---|
| Everett Neville | See Remarks | 20.3K · < 1% | Sale under a 10b5-1 plan, 3 Sep 2026 |
|---|
| Donna F. Zarcone | Director | 15.4K · < 1% | Grant or award, 22 Apr 2026 |
|---|
| Ann M. Dennison | EVP, CFO | 8.5K · < 1% | Shares withheld for tax, 27 Feb 2026 |
|---|
| Kathleen M. Mazzarella | Director | 6.1K · < 1% | Grant or award, 22 Apr 2026 |
|---|
| Mark B. McClellan, M.D., Ph.D. | Director | 6.1K · < 1% | Grant or award, 22 Apr 2026 |
|---|
| Eric C. Wiseman | Director | 4.7K · < 1% | Grant or award, 22 Apr 2026 |
|---|
| Kimberly Ross | Director | 4.5K · < 1% | Grant or award, 22 Apr 2026 |
|---|
| George Kurian | Director | 3.8K · < 1% | Grant or award, 22 Apr 2026 |
|---|
| Neesha Hathi | Director | 3.4K · < 1% | Grant or award, 22 Apr 2026 |
|---|
| Philip O. Ozuah, M.D., Ph.D. | Director | 1.8K | Grant or award, 22 Apr 2026 |
|---|
| Michael J. Hennigan | Director | 568 · < 1% | Grant or award, 22 Apr 2026 |
|---|
| Noelle K. Eder | See Remarks | 0 · < 1% | Sale under a 10b5-1 plan, 7 Mar 2025 |
|---|
| Kates Jamie G | Chief Accounting Officer | — | Option exercise, 12 Jun 2026 |
|---|
| Koka Durga Prasad | EVP, Global CIO | — | Shares withheld for tax, 1 Jun 2026 |
|---|
| BRAILER DAVID J | EVP & Chief Health Officer | — | Shares withheld for tax, 29 Aug 2025 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
CI in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.